OPACRISPRプラスミド
サンタクルスバイオテクノロジー社は遺伝子サイレンシング用のCRISPR/Cas9ノックアウト及びCRISPR Double Nickaseプラスミドを含め、広範囲の遺伝子編集製品を提供しております。OPA遺伝子サイレンサーは、OPA CRISPR/Cas9ノックアウトプラスミドとOPADouble Nickaseプラスミドとして利用可能です。遺伝子活性化用のOPACRISPR/dCas9 Activationプラスミド及びCRISPR Lenti Activationシステムも利用できます。遺伝子サイレンサーと活性化剤はタンパク質の検出に使用された抗体と組み合わせた遺伝子研究に有用です。
OPA CRISPR Knockout, HDR and Double Nickase Plasmids
| Empty Table Header | 製品名 | CATALOG # | Species | アプリケーション | MARKER | 引用文献 | レーティング |
|---|---|---|---|---|---|---|---|
OPA1 CRISPR/Cas9 KOプラスミド (h) | sc-401555 | h | Gene Knockout | GFP | 0 | ||
OPA1 HDRプラスミド (h) | sc-401555-HDR | h | Homology Directed Repair | Puromycin | 0 | ||
OPA1 Double Nickaseプラスミド (h) | sc-401555-NIC | h | Gene Knockout | Puromycin | 0 | ||
OPA1 Double Nickaseプラスミド (h2) | sc-401555-NIC-2 | h | Gene Knockout | Puromycin | 0 | ||
OPA1 CRISPR/Cas9 KOプラスミド (m) | sc-428749 | m | Gene Knockout | GFP | 0 | ||
OPA1 HDRプラスミド (m) | sc-428749-HDR | m | Homology Directed Repair | Puromycin | 0 | ||
OPA1 Double Nickaseプラスミド (m) | sc-428749-NIC | m | Gene Knockout | Puromycin | 0 | ||
OPA1 Double Nickaseプラスミド (m2) | sc-428749-NIC-2 | m | Gene Knockout | Puromycin | 0 | ||
OPA3 CRISPR/Cas9 KOプラスミド (h) | sc-408042 | h | Gene Knockout | GFP | 0 | ||
OPA3 HDRプラスミド (h) | sc-408042-HDR | h | Homology Directed Repair | Puromycin | 0 | ||
OPA3 Double Nickaseプラスミド (h) | sc-408042-NIC | h | Gene Knockout | Puromycin | 0 | ||
OPA3 Double Nickaseプラスミド (h2) | sc-408042-NIC-2 | h | Gene Knockout | Puromycin | 0 | ||
OPA3 CRISPR/Cas9 KOプラスミド (m) | sc-436519 | m | Gene Knockout | GFP | 0 | ||
OPA3 HDRプラスミド (m) | sc-436519-HDR | m | Homology Directed Repair | Puromycin | 0 | ||
OPA3 Double Nickaseプラスミド (m) | sc-436519-NIC | m | Gene Knockout | Puromycin | 0 | ||
OPA3 Double Nickaseプラスミド (m2) | sc-436519-NIC-2 | m | Gene Knockout | Puromycin | 0 |
OPA CRISPR Activation Products
| Empty Table Header | 製品名 | CATALOG # | Species | アプリケーション | MARKER | 引用文献 | レーティング |
|---|---|---|---|---|---|---|---|
OPA1 CRISPR Activationプラスミド (h) | sc-401555-ACT | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
OPA1 CRISPR Activationプラスミド (h2) | sc-401555-ACT-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
OPA1 Lentiviral Activation Particles (h) | sc-401555-LAC | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
OPA1 Lentiviral Activation Particles (h2) | sc-401555-LAC-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
OPA1 CRISPR Activationプラスミド (m) | sc-428749-ACT | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
OPA1 CRISPR Activationプラスミド (m2) | sc-428749-ACT-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
OPA1 Lentiviral Activation Particles (m) | sc-428749-LAC | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
OPA1 Lentiviral Activation Particles (m2) | sc-428749-LAC-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
OPA3 CRISPR Activationプラスミド (h) | sc-408042-ACT | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
OPA3 CRISPR Activationプラスミド (h2) | sc-408042-ACT-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
OPA3 Lentiviral Activation Particles (h) | sc-408042-LAC | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
OPA3 Lentiviral Activation Particles (h2) | sc-408042-LAC-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
OPA3 CRISPR Activationプラスミド (m) | sc-436519-ACT | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
OPA3 CRISPR Activationプラスミド (m2) | sc-436519-ACT-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
OPA3 Lentiviral Activation Particles (m) | sc-436519-LAC | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
OPA3 Lentiviral Activation Particles (m2) | sc-436519-LAC-2 | m | Gene Activation | Puro, Blast, Hygro | 0 |